Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Controlling a Van Hove singularity and Fermi surface topology at a complex oxide heterostructure interface.

Mori R, Marshall PB, Ahadi K, Denlinger JD, Stemmer S, Lanzara A.

Nat Commun. 2019 Dec 4;10(1):5534. doi: 10.1038/s41467-019-13046-z.

2.

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer.

Landman Y, Stemmer SM, Sulkes A, Neiman V, Granot T, Hendler D, Kramer MR, Gelmon K, Yerushalmi R.

J Oncol. 2019 Oct 28;2019:2584859. doi: 10.1155/2019/2584859. eCollection 2019.

3.

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy.

Stemmer SM, Steiner M, Rizel S, Ben-Baruch N, Uziely B, Jakubowski DM, Baron J, Shak S, Soussan-Gutman L, Bareket-Samish A, Fried G, Rosengarten O, Itay A, Nisenbaum B, Katz D, Leviov M, Tokar M, Liebermann N, Geffen DB.

NPJ Breast Cancer. 2019 Nov 8;5:41. doi: 10.1038/s41523-019-0137-3. eCollection 2019.

4.

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.

Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Petrakova K, Blackwell KL, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Mondal S, Su F, Miller M, Elmeliegy M, Germa C, O'Shaughnessy J.

Ann Oncol. 2019 Nov 1;30(11):1842. doi: 10.1093/annonc/mdz215. No abstract available.

5.

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.

Perez S, Kaspi A, Domovitz T, Davidovich A, Lavi-Itzkovitz A, Meirson T, Alison Holmes J, Dai CY, Huang CF, Chung RT, Nimer A, El-Osta A, Yaari G, Stemmer SM, Yu ML, Haviv I, Gal-Tanamy M.

PLoS Genet. 2019 Jun 19;15(6):e1008181. doi: 10.1371/journal.pgen.1008181. eCollection 2019 Jun.

6.

Enhancing superconductivity in SrTiO3 films with strain.

Ahadi K, Galletti L, Li Y, Salmani-Rezaie S, Wu W, Stemmer S.

Sci Adv. 2019 Apr 26;5(4):eaaw0120. doi: 10.1126/sciadv.aaw0120. eCollection 2019 Apr.

7.

Can posttraumatic growth after breast cancer promote positive coping?-A cross-lagged study.

Hamama-Raz Y, Pat-Horenczyk R, Roziner I, Perry S, Stemmer SM.

Psychooncology. 2019 Apr;28(4):767-774. doi: 10.1002/pon.5017. Epub 2019 Feb 14.

PMID:
30720241
8.

Dysregulation of the cohesin subunit RAD21 by Hepatitis C virus mediates host-virus interactions.

Perez S, Gevor M, Davidovich A, Kaspi A, Yamin K, Domovich T, Meirson T, Matityahu A, Brody Y, Stemmer SM, El-Osta A, Haviv I, Onn I, Gal-Tanamy M.

Nucleic Acids Res. 2019 Mar 18;47(5):2455-2471. doi: 10.1093/nar/gkz052.

9.

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial.

Golan T, Geva R, Richards D, Madhusudan S, Lin BK, Wang HT, Walgren RA, Stemmer SM.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):871-879. doi: 10.1002/jcsm.12331. Epub 2018 Jul 27.

10.

Treosulfan induces distinctive gonadal toxicity compared with busulfan.

Levi M, Stemmer SM, Stein J, Shalgi R, Ben-Aharon I.

Oncotarget. 2018 Apr 10;9(27):19317-19327. doi: 10.18632/oncotarget.25029. eCollection 2018 Apr 10.

11.

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.

Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Petrakova K, Blackwell KL, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Mondal S, Su F, Miller M, Elmeliegy M, Germa C, O'Shaughnessy J.

Ann Oncol. 2018 Jul 1;29(7):1541-1547. doi: 10.1093/annonc/mdy155.

12.

Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?

Ben-Aharon I, Levi M, Margel D, Yerushalmi R, Rizel S, Perry S, Sharon E, Hasky N, Abir R, Fisch B, Tobar A, Shalgi R, Stemmer SM.

Oncotarget. 2018 Mar 23;9(22):15931-15941. doi: 10.18632/oncotarget.24638. eCollection 2018 Mar 23.

13.

Non-Fermi liquids in oxide heterostructures.

Stemmer S, Allen SJ.

Rep Prog Phys. 2018 Jun;81(6):062502. doi: 10.1088/1361-6633/aabdfa. Epub 2018 Apr 13.

14.

Brain metastasis in gastroesophageal adenocarcinoma and HER2 status.

Limon D, Gal O, Gordon N, Katz L, Perl G, Purim O, Amit L, Stemmer SM, Kundel Y, Ben-Aharon I, Brenner B, Siegal T, Yust-Katz S.

J Neurooncol. 2018 Jun;138(2):315-320. doi: 10.1007/s11060-018-2798-4. Epub 2018 Feb 10.

PMID:
29429124
15.

A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic solid tumors.

Stemmer SM, Benjaminov O, Silverman MH, Sandler U, Purim O, Sender N, Meir C, Oren-Apoteker P, Ohana J, Devary Y.

Mol Clin Oncol. 2018 Jan;8(1):22-29. doi: 10.3892/mco.2017.1505. Epub 2017 Nov 15.

16.

Risk factors for recurrence of pressure ulcers after defect reconstruction.

Wurzer P, Winter R, Stemmer SO, Ivancic J, Lebo PB, Hundeshagen G, Cambiaso-Daniel J, Quehenberger F, Kamolz LP, Lumenta DB.

Wound Repair Regen. 2018 Jan;26(1):64-68. doi: 10.1111/wrr.12613. Epub 2018 Mar 7.

PMID:
29381242
17.

Observation of the Quantum Hall Effect in Confined Films of the Three-Dimensional Dirac Semimetal Cd_{3}As_{2}.

Schumann T, Galletti L, Kealhofer DA, Kim H, Goyal M, Stemmer S.

Phys Rev Lett. 2018 Jan 5;120(1):016801. doi: 10.1103/PhysRevLett.120.016801.

18.

dTCApFs, a derivative of a novel human hormone peptide, induces apoptosis in cancer cells through a mechanism involving loss of Golgi function.

Ohana J, Sandler U, Kass G, Stemmer SM, Devary Y.

Mol Clin Oncol. 2017 Dec;7(6):991-999. doi: 10.3892/mco.2017.1453. Epub 2017 Oct 17.

19.

Trichomonas vaginalis is most frequently detected in women at the age of peri-/premenopause: an unusual pattern for a sexually transmitted pathogen.

Stemmer SM, Mordechai E, Adelson ME, Gygax SE, Hilbert DW.

Am J Obstet Gynecol. 2018 Mar;218(3):328.e1-328.e13. doi: 10.1016/j.ajog.2017.12.006. Epub 2017 Dec 13.

PMID:
29247635
20.

Response of the Lattice across the Filling-Controlled Mott Metal-Insulator Transition of a Rare Earth Titanate.

Kim H, Marshall PB, Ahadi K, Mates TE, Mikheev E, Stemmer S.

Phys Rev Lett. 2017 Nov 3;119(18):186803. doi: 10.1103/PhysRevLett.119.186803. Epub 2017 Nov 2.

21.

A global comparison of the cost of patented cancer drugs in relation to global differences in wealth.

Goldstein DA, Clark J, Tu Y, Zhang J, Fang F, Goldstein R, Stemmer SM, Rosenbaum E.

Oncotarget. 2017 May 9;8(42):71548-71555. doi: 10.18632/oncotarget.17742. eCollection 2017 Sep 22.

22.

A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer.

Goldstein DA, Gordon N, Davidescu M, Leshno M, Steuer CE, Patel N, Stemmer SM, Zer A.

J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx063.

PMID:
29059432
23.

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.

Moore A, Cohen-Naftaly M, Tobar A, Kundel Y, Benjaminov O, Braun M, Issachar A, Mor E, Sarfaty M, Bragilovski D, Hur RB, Gordon N, Stemmer SM, Allen AM.

Radiat Oncol. 2017 Oct 19;12(1):163. doi: 10.1186/s13014-017-0899-4.

24.

Trajectories of Injectable Cancer Drug Costs After Launch in the United States.

Gordon N, Stemmer SM, Greenberg D, Goldstein DA.

J Clin Oncol. 2018 Feb 1;36(4):319-325. doi: 10.1200/JCO.2016.72.2124. Epub 2017 Oct 10.

PMID:
29016226
25.

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry.

Stemmer SM, Steiner M, Rizel S, Soussan-Gutman L, Ben-Baruch N, Bareket-Samish A, Geffen DB, Nisenbaum B, Isaacs K, Fried G, Rosengarten O, Uziely B, Svedman C, McCullough D, Maddala T, Klang SH, Zidan J, Ryvo L, Kaufman B, Evron E, Karminsky N, Goldberg H, Shak S, Liebermann N.

NPJ Breast Cancer. 2017 Sep 8;3:33. doi: 10.1038/s41523-017-0034-6. eCollection 2017.

26.

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry.

Stemmer SM, Steiner M, Rizel S, Geffen DB, Nisenbaum B, Peretz T, Soussan-Gutman L, Bareket-Samish A, Isaacs K, Rosengarten O, Fried G, McCullough D, Svedman C, Shak S, Liebermann N, Ben-Baruch N.

NPJ Breast Cancer. 2017 Sep 8;3:32. doi: 10.1038/s41523-017-0033-7. eCollection 2017.

27.

Disorder versus two transport lifetimes in a strongly correlated electron liquid.

Marshall PB, Kim H, Stemmer S.

Sci Rep. 2017 Sep 4;7(1):10312. doi: 10.1038/s41598-017-10841-w.

28.

Novel Metal-Insulator Transition at the SmTiO_{3}/SrTiO_{3} Interface.

Ahadi K, Stemmer S.

Phys Rev Lett. 2017 Jun 9;118(23):236803. doi: 10.1103/PhysRevLett.118.236803. Epub 2017 Jun 9.

29.

[FERTILITY PRESERVATION IN YOUNG CANCER PATIENTS - CAN WE OPTIMIZE THE PATH?]

Ben-Aharon I, Ash S, Ben-Haroush A, Perl G, Oron G, Pinkas H, Freud N, Kravarusic D, Abir R, Sapir O, Wiznitzer A, Brenner B, Yaniv I, Stemmer S, Fisch B.

Harefuah. 2017 May;156(5):326-329. Review. Hebrew.

PMID:
28551906
30.

Potential Fluctuations at Low Temperatures in Mesoscopic-Scale SmTiO3/SrTiO3/SmTiO3 Quantum Well Structures.

Hardy WJ, Isaac B, Marshall P, Mikheev E, Zhou P, Stemmer S, Natelson D.

ACS Nano. 2017 Apr 25;11(4):3760-3766. doi: 10.1021/acsnano.6b08427. Epub 2017 Mar 30.

PMID:
28350436
31.

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobsen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E, Marschner N, Favret AM, Yardley D, Bachelot T, Tseng LM, Blau S, Xuan F, Souami F, Miller M, Germa C, Hirawat S, O'Shaughnessy J.

N Engl J Med. 2016 Nov 3;375(18):1738-1748. Epub 2016 Oct 7. Erratum in: N Engl J Med. 2018 Dec 27;379(26):2582.

32.

The cost and value of cancer drugs - are new innovations outpacing our ability to pay?

Goldstein DA, Stemmer SM, Gordon N.

Isr J Health Policy Res. 2016 Sep 22;5:40. doi: 10.1186/s13584-016-0097-0. eCollection 2016.

33.

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study.

Granot T, Gordon N, Perry S, Rizel S, Stemmer SM.

PLoS One. 2016 Sep 28;11(9):e0162813. doi: 10.1371/journal.pone.0162813. eCollection 2016.

34.

Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.

Popovtzer A, Burnstein H, Stemmer S, Limon D, Hili O, Bachar G, Sopov V, Feinmesser R, Groshar D, Shvero J.

Head Neck. 2017 Feb;39(2):227-233. doi: 10.1002/hed.24571. Epub 2016 Aug 24.

PMID:
27556178
35.

Young patients and gastrointestinal (GI) tract malignancies - are we addressing the unmet needs?

Perl G, Nordheimer S, Lando S, Benedict C, Brenner B, Perry S, Shmoisman G, Purim O, Amit L, Stemmer SM, Ben-Aharon I.

BMC Cancer. 2016 Aug 12;16:630. doi: 10.1186/s12885-016-2676-4.

36.

Optimizing the process of fertility preservation in pediatric female cancer patients - a multidisciplinary program.

Ben-Aharon I, Abir R, Perl G, Stein J, Gilad G, Toledano H, Elitzur S, Avrahami G, Ben-Haroush A, Oron G, Freud E, Kravarusic D, Ben-Arush M, Herzel G, Yaniv I, Stemmer SM, Fisch B, Ash S.

BMC Cancer. 2016 Aug 9;16:620. doi: 10.1186/s12885-016-2584-7.

37.

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.

Zielinski C, Láng I, Inbar M, Kahán Z, Greil R, Beslija S, Stemmer SM, Zvirbule Z, Steger GG, Melichar B, Pienkowski T, Sirbu D, Petruzelka L, Eniu A, Nisenbaum B, Dank M, Anghel R, Messinger D, Brodowicz T; TURANDOT investigators.

Lancet Oncol. 2016 Sep;17(9):1230-9. doi: 10.1016/S1470-2045(16)30154-1. Epub 2016 Aug 5.

PMID:
27501767
38.

Pseudogaps and Emergence of Coherence in Two-Dimensional Electron Liquids in SrTiO_{3}.

Marshall PB, Mikheev E, Raghavan S, Stemmer S.

Phys Rev Lett. 2016 Jul 22;117(4):046402. doi: 10.1103/PhysRevLett.117.046402. Epub 2016 Jul 22.

PMID:
27494486
39.

Probing the Metal-Insulator Transition in BaTiO_{3} by Electrostatic Doping.

Raghavan S, Zhang JY, Shoron OF, Stemmer S.

Phys Rev Lett. 2016 Jul 15;117(3):037602. doi: 10.1103/PhysRevLett.117.037602. Epub 2016 Jul 14.

40.

Interface-Driven Ferromagnetism within the Quantum Wells of a Rare Earth Titanate Superlattice.

Need RF, Isaac BJ, Kirby BJ, Borchers JA, Stemmer S, Wilson SD.

Phys Rev Lett. 2016 Jul 15;117(3):037205. doi: 10.1103/PhysRevLett.117.037205. Epub 2016 Jul 12.

PMID:
27472135
41.

Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience.

Moore A, Cohen-Naftaly M, Benjaminov O, Braun M, Issachar A, Mor E, Tovar A, Sarfaty M, Gordon N, Stemmer SM.

J Cancer. 2016 Apr 29;7(8):883-9. doi: 10.7150/jca.14721. eCollection 2016.

42.

Cetuximab intensifies cisplatin-induced testicular toxicity.

Levi M, Popovtzer A, Tzabari M, Mizrachi A, Savion N, Stemmer SM, Shalgi R, Ben-Aharon I.

Reprod Biomed Online. 2016 Jul;33(1):102-10. doi: 10.1016/j.rbmo.2016.04.004. Epub 2016 Apr 20.

PMID:
27184186
43.

Stability and transitions in posttraumatic growth trajectories among cancer patients: LCA and LTA analyses.

Pat-Horenczyk R, Saltzman LY, Hamama-Raz Y, Perry S, Ziv Y, Ginat-Frolich R, Stemmer SM.

Psychol Trauma. 2016 Sep;8(5):541-9. doi: 10.1037/tra0000094. Epub 2016 Apr 11.

PMID:
27065063
44.

Key role of lattice symmetry in the metal-insulator transition of NdNiO3 films.

Zhang JY, Kim H, Mikheev E, Hauser AJ, Stemmer S.

Sci Rep. 2016 Apr 1;6:23652. doi: 10.1038/srep23652.

45.

Carrier density independent scattering rate in SrTiO3-based electron liquids.

Mikheev E, Raghavan S, Zhang JY, Marshall PB, Kajdos AP, Balents L, Stemmer S.

Sci Rep. 2016 Feb 10;6:20865. doi: 10.1038/srep20865.

46.

Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.

Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, Ben-Haroush A, Freud E, Kravarusic D, Sapir O, Fisch B.

Hum Reprod. 2016 Apr;31(4):750-62. doi: 10.1093/humrep/dew007. Epub 2016 Feb 4.

PMID:
26848188
47.

Widespread morbilliform rash due to sorafenib or vemurafenib treatment for advanced cancer; experience of a tertiary dermato-oncology clinic.

Ollech A, Stemmer SM, Merims S, Lotem M, Popovtzer A, Hendler D, Hodak E, Didkovsky E, Amitay-Laish I.

Int J Dermatol. 2016 Apr;55(4):473-8. doi: 10.1111/ijd.13153. Epub 2016 Jan 29.

PMID:
26825962
48.

Pasireotide for malignant insulinoma.

Tirosh A, Stemmer SM, Solomonov E, Elnekave E, Saeger W, Ravkin Y, Nir K, Talmor Y, Shimon I.

Hormones (Athens). 2016 Apr;15(2):271-276. doi: 10.14310/horm.2002.1639.

49.

Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.

Domchek SM, Aghajanian C, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmaña J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, Loman N, Robertson JD, Mann H, Kaufman B.

Gynecol Oncol. 2016 Feb;140(2):199-203. doi: 10.1016/j.ygyno.2015.12.020. Epub 2015 Dec 23.

50.

Doctor-patient hierarchy may have a therapeutic role.

Limon D, Stemmer SM.

BMJ. 2015 Dec 23;351:h6906. doi: 10.1136/bmj.h6906. No abstract available.

PMID:
26699163

Supplemental Content

Loading ...
Support Center